Cargando...

“The Google of Healthcare”: Enabling the privatization of genetic bio/databanking

PURPOSE: 23andMe is back on the market as the first direct-to-consumer genetic testing company that “includes reports that meet Food and Drug Administration (FDA) standards….” But, whereas its front-end product is selling individual genetic tests online, its back-end business model is amassing one o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Epidemiol
Autor principal: Spector-Bagdady, Kayte
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6988384/
https://ncbi.nlm.nih.gov/pubmed/27449572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.annepidem.2016.05.007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!